Northern Trust’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.34M Sell
596,883
-105,634
-15% -$1.48M ﹤0.01% 2180
2025
Q1
$9.47M Buy
702,517
+8,375
+1% +$113K ﹤0.01% 2067
2024
Q4
$13.3M Buy
694,142
+112,534
+19% +$2.16M ﹤0.01% 1953
2024
Q3
$13.2M Buy
581,608
+101,727
+21% +$2.31M ﹤0.01% 1898
2024
Q2
$6.24M Buy
479,881
+17,201
+4% +$224K ﹤0.01% 2269
2024
Q1
$8.1M Buy
462,680
+49,039
+12% +$859K ﹤0.01% 2180
2023
Q4
$9.01M Buy
413,641
+11,975
+3% +$261K ﹤0.01% 2143
2023
Q3
$6.16M Sell
401,666
-4,199
-1% -$64.4K ﹤0.01% 2315
2023
Q2
$9.66M Buy
405,865
+34,939
+9% +$831K ﹤0.01% 2094
2023
Q1
$9.44M Buy
370,926
+9,237
+3% +$235K ﹤0.01% 2056
2022
Q4
$10.6M Buy
361,689
+88,878
+33% +$2.6M ﹤0.01% 1968
2022
Q3
$5.6M Buy
272,811
+28,855
+12% +$592K ﹤0.01% 2404
2022
Q2
$2.82M Buy
243,956
+187,469
+332% +$2.17M ﹤0.01% 2862
2022
Q1
$1.04M Sell
56,487
-2,841
-5% -$52.5K ﹤0.01% 3402
2021
Q4
$1.17M Buy
59,328
+24,677
+71% +$488K ﹤0.01% 3478
2021
Q3
$570K Buy
34,651
+3,184
+10% +$52.4K ﹤0.01% 3721
2021
Q2
$576K Buy
+31,467
New +$576K ﹤0.01% 3664
2020
Q4
Sell
-4,862
Closed -$56K 4419
2020
Q3
$56K Buy
4,862
+1,143
+31% +$13.2K ﹤0.01% 4090
2020
Q2
$62K Sell
3,719
-381
-9% -$6.35K ﹤0.01% 4018
2020
Q1
$27K Buy
4,100
+1,042
+34% +$6.86K ﹤0.01% 4047
2019
Q4
$22K Hold
3,058
﹤0.01% 4150
2019
Q3
$33K Sell
3,058
-14,274
-82% -$154K ﹤0.01% 4103
2019
Q2
$533K Sell
17,332
-1,154
-6% -$35.5K ﹤0.01% 3539
2019
Q1
$773K Sell
18,486
-41
-0.2% -$1.71K ﹤0.01% 3438
2018
Q4
$842K Buy
18,527
+27
+0.1% +$1.23K ﹤0.01% 3417
2018
Q3
$1.55M Buy
18,500
+193
+1% +$16.2K ﹤0.01% 3336
2018
Q2
$1.76M Buy
18,307
+6,889
+60% +$662K ﹤0.01% 3266
2018
Q1
$1.2M Buy
11,418
+2,370
+26% +$249K ﹤0.01% 3326
2017
Q4
$1.42M Sell
9,048
-706
-7% -$110K ﹤0.01% 3293
2017
Q3
$1.34M Buy
9,754
+1,797
+23% +$247K ﹤0.01% 3365
2017
Q2
$1.54M Buy
+7,957
New +$1.54M ﹤0.01% 3307